Simple Summary Patients with lung cancer have high rates of brain metastasis (BM).
Despite available therapies, patient prognosis is poor. Studies have shown genetic …

Smoking is associated with lung cancer and has a profound impact on tumor immunity.
Nicotine, the addictive and non-carcinogenic smoke component, influences various brain …

Increased survival (due to the use of targeted therapies based on genomic profiling) has
resulted in the increased incidence of brain metastasis during the course of disease, and …

Background Preoperative assessment of the acquired resistance T790M mutation in patients
with metastatic non‐small cell lung cancer (NSCLC) based on brain metastasis (BM) is …

Background Non-small cell lung cancer (NSCLC), the most primary lung cancer subtype,
threatens human health globally. Long non-coding RNAs (lncRNAs) have been uncovered …

Background Patients with non-small cell lung cancer (NSCLC) who develop brain
metastases (BM) have a poor prognosis. This study aimed to construct a clinical prediction …

Simple Summary Non-small cell lung cancer (NSCLC) accounts for 80–85% of primary lung
cancers. Radiation therapy is widely used to treat both primary NSCLC and lung cancer that …

Background Neurosurgery is the standard of care for resectable solitary brain metastasis
(BM) from non-small cell lung cancer (NSCLC), but still with a poor outcome. Postoperative …

Abstract Background Brain metastasis (BrM) is prevalent among patients with NSCLC, and
surgical resection of BrM constitutes a promising treatment strategy for local management …

Nonsmall cell lung cancer (NSCLC) is a serious threat to the life and health of patients with
high incidence rate and mortality. The present research was to assess the relationship …